An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination

• DOI: 10.1080/21645515.2024.2321672
• Publication Date: 2024-03-05T07:55:46Z
• Authors: Zixin Li; Shijie Chen; Mingyi Zhao
• Keywords: 2019-20 coronavirus outbreak

To prevent COVID-19, the COVID-19 vaccine has been widely administered worldwide, but various complications accompany this vaccine. The aim of study was to investigate demographic patterns, clinical features, diagnostic findings, and treatment outcomes associated with shoulder injury related administration (SIRVA). This examined 22 patients SIRVA following vaccination from Web Science (WOS) PubMed databases. were categorized based on sex, age, type received, dose administered, latency symptom onset, presence specific manifestations. Patients, evenly distributed by sex (12 females, 10 males), aged 21 84 years (mean age 46.6), analyzed. cases reported across all groups. Pfizer - BioNTech had highest incidence (n = 8), followed Oxford/AstraZeneca 4). Symptoms, primarily pain 22) mobility disorders 18), occurred within three days post-vaccination. Some also swelling 5) fever 2). Imaging revealed nonspecific X-ray supraspinatus tendon calcification 2), edema inflammation MRI 12). provides insights into aspects vaccination. Recognition appropriate management these are crucial for optimal patient outcomes.